glp-1 diarrhea class action in michigan lawsuit Ozempic Lawsuit [May 2026 Update] GLP-1 Overdose & Pharmaceutical Negligence

As the nations largest compounding pharmacy, Empower Pharmacy provides a range of customized, integrative therapies that meet your patients specific needs

Compounded semaglutide/tirzepatide will phase out by late May 2025, so prepare to switch to FDA-approved products

The Glucagon-like peptide-1 (GLP-1) ELISA kit provides materials for the quantitative measurement of GLP-1 in EDTA plasma and other biological fluids.

Summary Retatrutide, a triple agonist now in phase 3 trials, has the potential to become the most effective pharmacological treatment for obesity while also offering substantial benefits in T2D management and other cardiometabolic risk factors.

While this doesnt negate their metabolic benefits, it highlights a crucial aspect of long-term patient care